TrakCel

company

About

Integrated Supply Chain Management Technology Designed for the unique demands of Cell Therapy

  • 11 - 50

Details

Last Funding Type
Corporate Round
Industries
Clinical Trials,Collaboration,Supply Chain Management
Founded date
Sep 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

TrakCel's proven technology integrates and orchestrates every aspect of Autologous and Allogeneic supply chains in a scalable, compliant and validated technology platform.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
TrakCel has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 3, 2021 from a Corporate Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 3, 2021 Corporate Round 2 LabCorp
AmerisourceBergen
Detail

Investors

Number of Lead Investors
Number of Investors
2
2
TrakCel is funded by 2 investors. LabCorp and AmerisourceBergen are the most recent investors.
Investor Name Lead Investor Funding Round
LabCorp Yes Corporate Round
AmerisourceBergen Yes Corporate Round